Donald Abrams, MD
Hassan Azari. PhD
Lorraine Collins, PhD
Robert Cook, MD
Ziva Cooper, PhD
Krystal Hemmingway, BSN, RN, FNP/DNP Student
Yan Wang, PhD
This CME activity consists of an educational component (slides, audio lecture) in an electronic format, followed by an online post-test. Estimated time to complete this activity, including review of materials, is 3.5 hours.
As a result of participation in this activity, participants should be able to:
- Identify potential risks and benefits of cannabis and cannabinoids for the treatment of pain.
- Distinguish between cannabis and cannabinoids within research and clinical settings.
- Describe the potential adverse events associated with cannabis and cannabinoids.
The following speakers and planning committee members have an affiliation/financial interest in the following areas:
- Dr. Ziva Cooper, PhD- Consultant, FSD Pharma
- Dr. Donald Abrams, MD- Consultant Maui Grown Therapies; Stock Shareholder-Lumen, Cannformatics, AXIM
- Dr. Almut Winterstein, R.Ph., Ph.D., FISPE- Consultant- Arbor Pharmaceuticals; Grants/Research Support-Merck, Sharp &
The following speakers and planning committee members have no relevant financial relationships to disclose:
- Dr. Lorraine Collins, PhD
- Dr. Amie Goodin, PhD, MPP
- Dr. Jeevan Jyot, PhD, PMP
- Dr. Yan Wang, PhD
- Dr. Robert Cook, MD
- Ms. Anna Shavers, MPA
- Dr. Hassan Azari. PhD
- Ms Krystal Hemmingway, BSN, RN, FNP/DNP Student
No one else in a position to control content has any financial relationship(s) to disclose.
CME Advisory Committee Disclosure
Conflict of interest information for the CME Advisory Committee members can be found on the
following website: https://cme.ufl.edu/disclosure/ (Links to an external site.)
Continuing Medical Education Credit
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Primary Care Physicians, Specialty Physicians
Resources for Further Study
- National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); 2017 Jan 12. PMID: 28182367 (Links to an external site.).
- Jugl S, Okpeku A, Costales B, Morris E, J, Alipour-Haris G, Hincapie-Castillo J, M, Stetten N, E, Sajdeya R, Keshwani S, Joseph V, Zhang Y, Shen Y, Adkins L, Winterstein A, G, Goodin A: A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019. Med Cannabis Cannabinoids 2021. doi: 10.1159/000515069 (Links to an external site.)
For questions, email us at firstname.lastname@example.org.
Registration is currently closed